Results 201 to 210 of about 88,192 (248)

Management of Latent Tuberculosis Infection

JAMA, 2023
This JAMA Insights Clinical Update examines treatment recommendations and therapy options among adults with latent tuberculosis infection.
Steven, Kim   +2 more
openaire   +2 more sources

Latent Mycobacterium tuberculosis Infection

New England Journal of Medicine, 2015
The natural history of tuberculosis begins with the inhalation of Mycobacterium tuberculosis organisms; a period of bacterial replication and dissemination ensues, followed by immunologic containment of viable bacilli. The result of this process is asymptomatic latent tuberculosis infection, which is defined as a state of persistent bacterial viability,
Getahun, Haileyesus   +3 more
openaire   +8 more sources

Treatment of Latent Tuberculosis Infection

Annals of Internal Medicine, 2015
possible comparisons, 42 (40%) were compared directly. Compared with placebo, isoniazid for 6 months (odds ratio [OR], 0.64 [95% credible interval {CrI}, 0.48 to 0.83]) or 12 months or longer (OR, 0.52 [CrI, 0.41 to 0.66]), rifampicin for 3 to 4 months (OR, 0.41 [CrI, 0.18 to 0.86]), rifapentine-isoniazid (OR, 0.61 [CrI, 0.29 to 1.22]), and rifampicin ...
Dominik, Zenner   +3 more
  +7 more sources

Latent Tuberculosis Infection

Seminars in Respiratory and Critical Care Medicine, 2004
Latent tuberculosis infection (LTBI) is a clinical condition characterized by a positive tuberculin skin test in the absence of clinical or radiological signs of active tuberculosis disease. It has been estimated that one third of the world's population is latently infected with Mycobacterium tuberculosis and serves as an enormous reservoir for future ...
Eric, Nuermberger   +2 more
openaire   +2 more sources

Treatment of latent tuberculosis infection

Seminars in Respiratory Infections, 2003
Treatment of latent tuberculosis infection (LTBI) is considered an essential component of TB control programs in several industrialized countries and is being used in selected situations in developing countries. In 2000, the American Thoracic Society (ATS) and Centers for Disease Control and Prevention (CDC) published new recommendations on the ...
DE ROSA, Francesco Giuseppe   +1 more
openaire   +3 more sources

Latent Tuberculosis Infection and BCG Vaccination

Journal of Midwifery & Women's Health, 2005
One third of the world's population is infected with Mycobacterium tuberculosis, and 5% to 10% of those infected will develop active disease. Identification and treatment of latent tuberculosis infection (LTBI) is an essential part of the public health strategy to control the spread of TB.
Lisa, Ross, Meredith, Goff
openaire   +2 more sources

Home - About - Disclaimer - Privacy